PROK ProKidney Corp.
Healthcare$1.69-3.43%ClosedMarket Cap: $544.6M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$4.67
Target (Median)
$5.00
Target Range
$3.00 - $6.00
Upside from current price: 176.3%
Rating Distribution
0 Strong Buy4 Buy2 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-07-15 | UBS | maintain | Buy | Buy |
| 2025-07-14 | Guggenheim | maintain | Buy | Buy |
| 2025-07-09 | Citigroup | maintain | Buy | Buy |
| 2025-06-30 | B of A Securities | downgrade | Underperform | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.66 | $449.8K | 4 |
| Sun Dec 31 | $-0.37 | $58.1M | 3 |
| Mon Dec 31 | $-0.27 | $128.6M | 1 |
| Tue Dec 31 | $0.09 | $333.8M | 1 |